Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Beauty Health (SKIN) Operating Expenses (2020 - 2026)

SkinHealth Systems has reported Operating Expenses over the past 6 years, most recently at $52.9 million for Q4 2025.

  • Quarterly Operating Expenses fell 11.14% to $52.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $217.2 million through Dec 2025, down 13.16% year-over-year, with the annual reading at $217.2 million for FY2025, 13.16% down from the prior year.
  • Operating Expenses was $52.9 million for Q4 2025 at SkinHealth Systems, up from $51.9 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $81.0 million in Q2 2023 and troughed at $29.4 million in Q1 2021.
  • The 5-year median for Operating Expenses is $64.0 million (2021), against an average of $62.3 million.
  • Year-over-year, Operating Expenses surged 5188.99% in 2021 and then fell 22.18% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $64.0 million in 2021, then increased by 7.76% to $68.9 million in 2022, then decreased by 7.1% to $64.0 million in 2023, then fell by 7.09% to $59.5 million in 2024, then dropped by 11.14% to $52.9 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Operating Expenses are $52.9 million (Q4 2025), $51.9 million (Q3 2025), and $51.8 million (Q2 2025).